He said the latest PR reveals that Leronlimab doesn't work for GvHD and, therefore, it probably won't work for many of the other indications.

That's absolutely false. The GvHD was paused because of Covid, not because of the drug's failure.

With "longs" like that, who the hell needs shorts...?

Worse, he's doubling-down...

Quote:

---

The truth is this: leronlimab did not show efficacy in GvHD and the trial was discontinued.

---